Dystrophin: More than just the sum of its parts

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1804, Issue 9, 2010, Pages 1713-1722

  Le Rumeur, Elisabeth ^a   Winder, Steve J ^b   Hubert, Jean François ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Actin; Coiled coil; Cytoskeleton; Dystrophin; Intermediate filaments; Membrane binding; Membrane phospholipids; Microtubules; Muscular dystrophy; NNOS; Spectrin like repeats

Indexed keywords

ACTIN; CYTOKERATIN 19; DESMIN; DYSTROPHIN; F ACTIN; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; SPECTRIN; UTROPHIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SARCOLEMMA; TRANSGENIC MOUSE; ANIMAL; CHEMISTRY; METABOLISM; MOUSE; PROTEIN DOMAIN;

MUS;

ANIMALS; DYSTROPHIN; HUMANS; MICE; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 77955094457     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2010.05.001     Document Type: Review

References (136)

1. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517.
2. Koenig M., Beggs A., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Muller C., Lindlof M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 1989, 45:498-506.
3. Ervasti J.M. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim. Biophys. Acta 2007, 1772:108-117.
4. Aartsma-Rus A., Van Deutekom J.C., Fokkema I.F., Van Ommen G.J., Den Dunnen J.T. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006, 34:135-144.
5. Tuffery-Giraud S., Beroud C., Leturcq F., Yaou R.B., Hamroun D., Michel-Calemard L., Moizard M.P., Bernard R., Cossee M., Boisseau P., Blayau M., Creveaux I., Guiochon-Mantel A., de Martinville B., Philippe C., Monnier N., Bieth E., Khau Van Kien P., Desmet F.O., Humbertclaude V., Kaplan J.C., Chelly J., Claustres M. Genotype-phenotype analysis in 2, 405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum. Mutat. 2009, 30:934-945.
6. Beggs A., Hoffman E., Snyder J., Arahata K., Specht L., Shapiro F., Angelini C., Sugita H., Kunkel L. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am. J. Hum. Genet. 1991, 49:54-67.
7. England S., Nicholson L., Johnson M., Forrest S., Love D., Zubrzycka-Gaarn E., Bulman D., Harris J., Davies K. Very mild muscular dystrophy associated with the deletion of 46% of the dystrophin. Nature 1990, 343:180-182.
8. Koenig M., Monaco A.P., Kunkel L.M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 1988, 53:219-226.
9. Koenig M., Kunkel L.M. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem. 1990, 265:4560-4566.
10. Cross R.A., Stewart M., Kendrick-Jones J. Structural predictions for the central domain of dystrophin. FEBS Lett. 1990, 262:87-92.
11. Winder S., Gibson T., Kendrick-Jones J. Dystrophin and utrophin: the missing links!. FEBS Lett. 1995, 369:27-33.
12. Ohlendieck K. Characterisation of the dystrophin-related protein utrophin in highly purified skeletal muscle sarcolemma vesicles. Biochim. Biophys. Acta 1996, 1283:215-222.
13. Pascual J., Castresana J., Saraste M. Evolution of the spectrin repeat. Bioessays 1997, 19:811-817.
14. Thomas G., Newbern E., Korte C., Bales M., Muse S., Clark A., Kiehart D. Intragenic duplication and divergence in the spectrin superfamily of proteins. Mol. Biol. Evol. 1997, 14:1285-1295.
15. Jin H., Tan S., Hermanowski J., Bohm S., Pacheco S., McCauley J.M., Greener M.J., Hinits Y., Hughes S.M., Sharpe P.T., Roberts R.G. The dystrotelin, dystrophin and dystrobrevin superfamily: new paralogues and old isoforms. BMC Genomics 2007, 8:19.
16. Sherratt T.G., Vulliamy T., Strong P.N. Evolutionary conservation of the dystrophin central rod domain. Biochem. J. 1992, 287:755-799.
17. Davison M.D., Critchley D.R. alpha-Actinins and the DMD protein contain spectrin-like repeats. Cell 1988, 52:159-160.
18. Kahana E., Marsh P.J., Henry A.J., Way M., Gratzer W.B. Conformation and phasing of dystrophin structural repeats. J. Mol. Biol. 1994, 235:1271-1277.
19. Kahana E., Gratzer W.B. Minimum folding unit of dystrophin rod domain. Biochemistry (Mosc.) 1995, 34:8110-8114.
20. Kahana E., Flood G., Gratzer W.B. Physical properties of dystrophin rod domain. Cell Motil. Cytoskeleton 1997, 36:246-252.
21. Calvert R., Kahana E., Gratzer W.B. Stability of the dystrophin rod domain fold: evidence for nested repeating units. Biophys. J. 1996, 71:1605-1610.
22. Saadat L., Pittman L., Menhart N. Structural cooperativity in spectrin type repeats motifs of dystrophin. Biochim. Biophys. Acta 2006, 1764:943-954.
23. Legardinier S., Hubert J.-F., Le Bihan O., Tascon C., Rocher C., Raguénès-Nicol C., Bondon A., Hardy S., Le Rumeur E. Sub-domains of the dystrophin rod domain display contrasting lipid-binding and stability properties. Biochim. Biophys. Acta 2008, 1784:672-682.
24. Mirza A., Menhart N. Stability of dystrophin STR fragments in relation to junction helicity. Biochim. Biophys. Acta 2008, 1784:1301-1309.
25. Legardinier S., Raguénès-Nicol C., Tascon C., Rocher C., Hardy S., Hubert J.F., Le Rumeur E. Mapping of the lipid-binding and stability properties of the central rod domain of human dystrophin. J. Mol. Biol. 2009, 389:546-558.
26. Ruszczak C., Mirza A., Menhart N. Differential stabilities of alternative exon-skipped rod motifs of dystrophin. Biochim. Biophys. Acta 2009, 1794:921-928.
27. Amann K.J., Renley B.A., Ervasti J.M. A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction. J. Biol. Chem. 1998, 273:28419-28423.
28. Amann K.J., XGuo A.W., Ervasti J.M. Utrophin lacks the rod domain actin binding activity of dystrophin. J. Biol. Chem. 1999, 274:35375-35380.
29. Menhart N. Hybrid spectrin type repeats produced by exon-skipping in dystrophin. Biochim. Biophys. Acta 2006, 1764:993-999.
30. Pantazatos D.P., MacDonald R.I. Site-directed mutagenesis of either the highly conserved Trp-22 or the moderately conserved Trp-95 to a large, hydrophobic residue reduces the thermodynamic stability of a spectrin repeating unit. J. Biol. Chem. 1997, 272:21052-21059.
31. MacDonald R., Cumming J. Stabilities of folding of clustered, two-repeat fragments of spectrin reveal a potential hinge in the human erythroid spectrin tetramer. Proc. Natl. Acad. Sci. USA 2004, 101:1502-1507.
32. Kusunoki H., MacDonald R., Mondragon A. Structural insights onto the stability and flexibility of unusual erythroid spectrin repeats. Structure 2004, 12:645-656.
33. Bhasin N., Law R., Liao G., Safer D., Ellmer J., Discher B.M., Sweeney H.L., Discher D.E. Molecular extensibility of mini-dystrophins and a dystrophin rod construct. J. Mol. Biol. 2005, 352:795-806.
34. An X., Guo X., Zhang X., Baines A.J., Debnath G., Moyo D., Salomao M., Bhasin N., Johnson C., Discher D., Gratzer W.B., Mohandas N. Conformational stabilities of the structural repeats of erythroid spectrin and their functional implications. J. Biol. Chem. 2006, 281:10527-10532.
35. An X., Zhang X., Salomao M., Guo X., Yang Y., Wu Y., Gratzer W., Baines A.J., Mohandas N. Thermal stabilities of brain spectrin and the constituent repeats of subunits. Biochemistry (Mosc.) 2006, 45:13670-13676.
36. Batey S., Clarke J. The folding pathway of a single domain in a multidomain protein is not affected by its neighbouring domain. J. Mol. Biol. 2008, 378:297-301.
37. MacDonald R., Pozharski E. Free energies of urea and thermal unfolding show that two tandem repeats of spectrin are thermodynamically more stable than a single repeat. Biochemistry (Mosc.) 2001, 40:3974-3984.
38. Wensley B.G., Batey S., Bone F.A., Chan Z.M., Tumelty N.R., Steward A., Kwa L.G., Borgia A., Clarke J. Experimental evidence for a frustrated energy landscape in a three-helix-bundle protein family. Nature 2010, 463:685-688.
39. Pascual J., Pfuhl M., Rivas G., Pastore A., Saraste M. The spectrin repeat folds into a three-helix bundle in solution. FEBS Lett. 1996, 383:201-207.
40. Pascual J., Pfuhl M., Walther D., Saraste M. Solution structure of spectrin repeat: a left-handed antiparallel triple-helical coiled-coil. J. Mol. Biol. 1997, 273:740-751.
41. Grum V.L., Li D., MacDonald R.I., Mondragon A. Structures of two repeats of spectrin suggest models of flexibility. Cell 1999, 98:523-535.
42. Yan Y., Winograd E., Viel A., Cronin T., Harrison S., Branton D. Crystal structure of the repetitive segments of spectrin. Science 1993, 262:2027-2030.
43. Kusunoki H., Minasov G., MacDonald R., Mondragon A. Independent movement, dimerization and stability of tandem repeats of chicken brain alpha-spectrin. J. Mol. Biol. 2004, 344:495-511.
44. Davis L., Abdi K., Machius M., Brautigam C., Tomchick D.R., Bennett V., Michaely P. Localization and structure of the ankyrin-binding site on beta2-spectrin. J. Biol. Chem. 2009, 284:6982-6987.
45. Djinovic-Carugo K., Young P., Gaudel M., Saraste M. Structure of the a-actinin rod: molecular basis for cross linking of actin filaments. Cell 1999, 98:537-546.
46. Ylanne J., Scheffzek K., Young P., Saraste M. Crystal structure of the alpha-actinin rod reveals an extensive torsional twist. Structure 2001, 9:597-604.
47. Sjoblom B., Salmazo A., Djinovic-Carugo K. Alpha-actinin structure and regulation. Cell. Mol. Life Sci. 2008, 65:2688-2701.
48. Legardinier S., Legrand B., Raguénès-Nicol C., Bondon A., Hardy S., Tascon C., Le Rumeur E., Hubert J.F. A two amino-acid mutation encountered in Duchenne muscular dystrophy decreases stability of the R23 spectrin-like repeat of dystrophin. J. Biol. Chem. 2009, 284:8822-8832.
49. Pons F., Augier N., Heilig R., Leger J., Mornet D., Leger J.J. Isolated dystrophin molecules as seen by electron microscopy. Proc. Natl. Acad. Sci. USA 1990, 87:7851-7855.
50. Augier N., Leger J., Robert A., Pons F., Leger J.J., Mornet D. Proteolytic susceptibility of the central domain in chicken gizzard and skeletal muscle dystrophins. Biochim. Biophys. Acta 1992, 1138:297-304.
51. Chan Y.M., Kunkel L.M. In vitro expressed dystrophin fragments do not associate with each other. FEBS Lett. 1997, 410:153-159.
52. Rybakova I., Amann K., Ervasti J. A new model for the interaction of dystrophin with F-actin. J. Cell Biol. 1996, 135:661-672.
53. Rybakova I., Ervasti J. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J. Biol. Chem. 1997, 272:28771-28778.
54. Rybakova I., Humston J., Sonneman K., Ervasti J. Dystrophin and utrophin bind actin through distinct modes of contact. J. Biol. Chem. 2006, 281:9996-10001.
55. DeWolf C., McCauley P., Sikorski A.F., Winlove C.P., Bailey A.I., Kahana E., Pinder J.C., Gratzer W.B. Interaction of dystrophin fragments with model membranes. Biophys. J. 1997, 72:2599-2604.
56. Grzybek M., Chorzalska A., Bok E., Hryniewicz-Jankowska A., Czogalla A., Diakowski W., Sikorski A.F. Spectrin-phospholipid interactions. Existence of multiple kinds of binding sites?. Chem. Phys. Lipids 2006, 141:133-141.
57. Le Rumeur E., Fichou Y., Pottier S., Gaboriau F., Rondeau-Mouro C., Vincent M., Gallay J., Bondon A. Interaction of dystrophin rod domain with membrane phospholipids: evidence of a close proximity between tryptophan residues and lipids. J. Biol. Chem. 2003, 278:5993-6001.
58. Le Rumeur E., Pottier S., Da Costa G., Metzinger L., Mouret L., Rocher C., Fourage M., Rondeau-Mouro C., Bondon A. Binding of the dystrophin second repeat to membrane di-oleyl phospholipids is dependent upon lipid packing. Biochim. Biophys. Acta 2007, 1768:648-654.
59. An X., Guo X., Sum H., Morrow J., Gratzer W., Mohandas N. Phosphatidylserine binding sites in erythroid spectrin: location and implications for membrane stability. Biochemistry (Mosc.) 2004, 43:310-315.
60. Mokri B., Engel A.G. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 1975, 25:1111-1120.
61. Menke A., Jockusch H. Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J. Cell Sci. 1995, 108:727-733.
62. Straub V., Rafael J.A., Chamberlain J.S., Campbell K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 1997, 139:375-385.
63. Hutter O., Burton F., Bovell D. Mechanical properties of normal and mdx mouse sarcolemma: bearing on function of dystrophin. J. Muscle Res. Cell Motil. 1991, 12:585-589.
64. Petrof B.J., Shrager J.B., Stedmann H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 1993, 90:3710-3714.
65. Nguyen F., Cherel Y., Guigand L., Goubault-Leroux I., Wyers M. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies. J. Comp. Pathol. 2002, 126:100-108.
66. Mizuno Y. Prevention of myonecrosis in mdx mice: effect of immobilization by the local tetanus method. Brain Dev. 1992, 14:319-322.
67. Mokhtarian A., Lefaucheur J.P., Even P.C., Sebille A. Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration. J. Appl. Physiol. 1999, 86:924-931.
68. Etard C., Behra M., Ertzer R., Fischer N., Jesuthasan S., Blader P., Geisler R., Strahle U. Mutation in the delta-subunit of the nAChR suppresses the muscle defects caused by lack of Dystrophin. Dev. Dyn. 2005, 234:1016-1025.
69. Deconinck N., Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr. Neurol. 2007, 36:1-7.
70. Ervasti J.M. Costameres: the Achilles' heel of Herculean muscle. J. Biol. Chem. 2003, 278:13591-13594.
71. Hamill O., Martinac B. Molecular basis of mechanotransduction in living cells. Physiol. Rev. 2001, 81:685-740.
72. Sheetz M.P. Cell control by membrane-cytoskeleton adhesion. Nat. Rev. Mol. Cell Biol. 2001, 2:392-396.
73. Nichol J.A., Hutter O.F. Tensile strength and dilatational elasticity of giant sarcolemmal vesicles shed from rabbit muscle. J. Physiol. 1996, 493(Pt 1):187-198.
74. Serrano A.G., Perez-Gil J. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chem. Phys. Lipids 2006, 141:105-118.
75. Manno S., Takakuwa Y., Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine - skeletal protein interactions modulate membrane stability. Proc. Natl. Acad. Sci. USA 2002, 99:1943-1948.
76. Sens P., Gov N. Force balance and membrane shedding at the red-blood-cell surface. Phys. Rev. Lett. 2007, 98:018102.
77. Raucher D., Sheetz M.P. Characteristics of a membrane reservoir buffering membrane tension. Biophys. J. 1999, 77:1992-2002.
78. Sens P., Turner M.S. Budded membrane microdomains as tension regulators. Phys. Rev. E Stat. Nonlinear Soft Matter Phys. 2006, 73:031918.
79. Dulhunty A.F., Franzini-Armstrong C. The relative contributions of the folds and caveolae to the surface membrane of frog skeletal muscle fibres at different sarcomere lengths. J. Physiol. 1975, 250:513-539.
80. Levin K.R., Page E. Quantitative studies on plasmalemmal folds and caveolae of rabbit ventricular myocardial cells. Circ. Res. 1980, 46:244-255.
81. Harper S.Q., Hauser M.A., DelloRusso C., Duan D., Crawford R.W., Phelps S.F., Harper H.A., Robinson A.S., Engelhardt J.F., Brooks S.V., Chamberlain J.S. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 2002, 8:253-261.
82. Banks G.B., Combs A.C., Chamberlain J.R., Chamberlain J.S. Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin. Hum. Mol. Genet. 2008, 17:3975-3986.
83. Banks G.B., Chamberlain J.S., Froehner S.C. Truncated dystrophins can influence neuromuscular synapse structure. Mol. Cell. Neurosci. 2009, 40:433-441.
84. Broderick M.J., Winder S.J. Spectrin, alpha-actinin, and dystrophin. Adv. Protein Chem. 2005, 70:203-246.
85. Rybakova I.N., Patel J.R., Ervasti J.M. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J. Cell Biol. 2000, 150:1209-1214.
86. Pfuhl M., Winder S.J., Pastore A. Nebulin, a helical actin binding protein. EMBO J. 1994, 13:1782-1789.
87. Pfuhl M., Winder S., Castiglione Morelli M., Labeit S., Pastore A. Correlation between conformational and binding properties of nebulin repeats. J. Mol. Biol. 1996, 257:367-384.
88. Rybakova I.N., Patel J.R., Davies K.E., Yurchenco P.D., Ervasti J.M. Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin- deficient muscle. Mol. Biol. Cell 2002, 13:1512-1521.
89. Prochniewicz E., Henderson D., Ervasti J.M., Thomas D.D. Dystrophin and utrophin have distinct effects on the structural dynamics of actin. Proc. Natl. Acad. Sci. USA 2009, 106:7822-7827.
90. Hori S., Ohtani S. NguyenthiMan, G.E. Morris, The N-terminal half of dystrophin is protected from proteolysis in situ. Biochem. Biophys. Res. Commun. 1995, 209:1062-1067.
91. Sonnemann K.J., Fitzsimons D.P., Patel J.R., Liu Y., Schneider M.F., Moss R.L., Ervasti J.M. Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. Dev. Cell 2006, 11:387-397.
92. Hanft L.M., Rybakova I.N., Patel J.R., Rafael-Fortney J.A., Ervasti J.M. Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle. Proc. Natl. Acad. Sci. USA 2006, 103:5385-5390.
93. Bhosle R.C., Michele D.E., Campbell K.P., Li Z., Robson R.M. Interactions of intermediate filament protein synemin with dystrophin and utrophin. Biochem. Biophys. Res. Commun. 2006, 346:768-777.
94. Rezniczek G.A., Konieczny P., Nikolic B., Reipert S., Schneller D., Abrahamsberg C., Davies K.E., Winder S.J., Wiche G. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J. Cell Biol. 2007, 176:965-977.
95. Stone M.R., O'Neill A., Catino D., Bloch R.J. Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19. Mol. Biol. Cell 2005, 16:4280-4293.
96. Prins K.W., Humston J.L., Mehta A., Tate V., Ralston E., Ervasti J.M. Dystrophin is a microtubule-associated protein. J. Cell Biol. 2009, 186:363-369.
97. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995, 80:675-679.
98. Grozdanovic Z., Baumgarten H.G. Nitric oxide synthase in skeletal muscle fibers: a signaling component of the dystrophin-glycoprotein complex. Histol. Histopathol. 1999, 14:243-256.
99. Kobayashi Y.M., Rader E.P., Crawford R.W., Iyengar N.K., Thedens D.R., Faulkner J.A., Parikh S.V., Weiss R.M., Chamberlain J.S., Moore S.A., Campbell K.P. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008, 456:511-515.
100. Chao D.S., Gorospe J.R., Brenman J.E., Rafael J.A., Peters M.F., Froehner S.C., Hoffman E.P., Chamberlain J.S., Bredt D.S. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J. Exp. Med. 1996, 184:609-618.
101. Sander M., Chavoshan B., Harris S.A., Iannaccone S.T., Stull J.T., Thomas G.D., Victor R.G. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 2000, 97:13818-13823.
102. Wozniak A.C., Anderson J.E. The dynamics of the nitric oxide release-transient from stretched muscle cells. Int. J. Biochem. Cell Biol. 2009, 41:625-631.
103. Percival J.M., Anderson K.N., Gregorevic P., Chamberlain J.S., Froehner S.C. Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS ONE 2008, 3:e3387.
104. Torelli S., Brown S.C., Jimenez-Mallebrera C., Feng L., Muntoni F., Sewry C.A. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Neuropathol. Appl. Neurobiol. 2004, 30:540-545.
105. Decrouy A., Renaud J.M., Davis H.L., Lunde J.A., Dickson G., Jasmin B.J. Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability. Gene Ther. 1997, 4:401-408.
106. Adams M.E., Mueller H.A., Froehner S.C. In vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J. Cell Biol. 2001, 155:113-122.
107. Adams M.E., Tesch Y., Percival J.M., Albrecht D.E., Conhaim J.I., Anderson K., Froehner S.C. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed alpha-dystrobrevin. J. Cell Sci. 2008, 121:48-54.
108. Lai Y., Thomas G.D., Yue Y., Yang H.T., Li D., Long C., Judge L., Bostick B., Chamberlain J.S., Terjung R.L., Duan D. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J. Clin. Investig. 2009, 119:624-635.
109. Yamashita K., Suzuki A., Satoh Y., Ide M., Amano Y., Masuda-Hirata M., Hayashi Y.K., Hamada K., Ogata K., Ohno S. The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b. Biochem. Biophys. Res. Commun. 2010, 391:812-817.
110. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
111. Monaco A., Bertelson C., Liechti-Gallati S., Moser H., Kunkel L. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988, 2:90-95.
112. Flanigan K.M., Dunn D.M., von Niederhausern A., Soltanzadeh P., Gappmaier E., Howard M.T., Sampson J.B., Mendell J.R., Wall C., King W.M., Pestronk A., Florence J.M., Connolly A.M., Mathews K.D., Stephan C.M., Laubenthal K.S., Wong B.L., Morehart P.J., Meyer A., Finkel R.S., Bonnemann C.G., Medne L., Day J.W., Dalton J.C., Margolis M.K., Hinton V.J., Weiss R.B. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum. Mutat. 2009, 30:1657-1666.
113. Banks G.B., Chamberlain J.S. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. Curr. Top. Dev. Biol. 2008, 84:431-453.
114. Gardner K., Kearney J., Edwards J., Rafael-Fortney J. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy. Gene Ther. 2005, 13:744-751.
115. Dunckley M.G., Wells K.E., Piper T.A., Wells D.J., Dickson G. Independent localization of dystrophin N- and C-terminal regions to the sarcolemma of mdx mouse myofibres in vivo. J. Cell Sci. 1994, 107(Pt 6):1469-1475.
116. Helliwell T., Ellis J., Mountford R., Appleton R., Morris G. A Truncated Dystrophin Lacking the C-Terminal Domains Is Localized at the Muscle Membrane. Am. J. Hum. Genet. 1992, 50:508-514.
117. Bonucelli G., Sotgia F., Schubert W., Park D., Frank P., Woodman S., Insabato L., Cammer M., Minetti C., Lisanti M. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am. J. Pathol. 2003, 163:1663-1675.
118. Recan D., Chafey P., Leturcq F., Hugnot J., Vincent N., Tome F., Collin H., Simon D., Czernichow P., Nicholson L., Fardeau M., Kaplan J., Chelly J. Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?. J. Clin. Invest. 1992, 89:712-716.
119. Hoffman E., Carlos P., Garcia A., Chamberlain J., Angelini P.C., Lupski J., Fenwick R. Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy. Ann. Neurol. 1991, 30:605-610.
120. Winnard A.V., Klein C.J., Coovert D.D., Prior T., Papp A., Snyder P., Bulman D.E., Ray P.N., McAndrew P., King W., et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum. Mol. Genet. 1993, 2:737-744.
121. Winnard A.V., Mendell J.R., Prior T.W., Florence J., Burghes A.H. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am. J. Hum. Genet. 1995, 56:158-166.
122. Corrado K., Rafael J.A., Mills P.L., Cole N.M., Faulkner J.A., Wang K., Chamberlain J.S. Transgenic mdx mice expressing dystrophin with a deletion in the actin- binding domain display a "mild Becker" phenotype. J. Cell Biol. 1996, 134:873-884.
123. Cox G.A., Sunada Y., Campbell K.P., Chamberlain J.S. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat. Genet. 1994, 8:333-339.
124. Warner L., DelloRusso C., Crawford R., Rybakova I., Patel J., Ervasti J., Chamberlain J. Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum. Mol. Genet. 2002, 11:1095-1105.
125. Gaedigk R., Law D.J., Fitzgerald-Gustafson K.M., McNulty S.G., Nsumu N.N., Modrcin A.C., Rinaldi R.J., Pinson D., Fowler S.C., Bilgen M., Burns J., Hauschka S.D., White R.A. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene. Neuromuscul. Disord. 2006, 16:192-203.
126. Wang B., Li J., Xiao X. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. USA 2000, 97:13714-13719.
127. Watchko J., O'Day T., Wang B., Zhou L., Tang Y., Li J., Xiao X. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. Hum. Gene Ther. 2002, 13:1451-1460.
128. Sakamoto M., Yuasa K., Yoshimura M., Yokota T., Ikemoto T., Suzuki M., Dickson G., Miyagoe-Suzuki Y., Takeda S. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem. Biophys. Res. Commun. 2002, 293:1265-1272.
129. Judge L.M., Haraguchiln M., Chamberlain J.S. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. J. Cell Sci. 2006, 119:1537-1546.
130. Liu M., Yue Y., Harper S., Grange R., Chamberlain J., Duan D. Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol. Ther. 2005, 11:245-256.
131. Gregorevic P., Allen J.M., Minami E., Blankinship M.J., Haraguchi M., Meuse L., Finn E., Adams M.E., Froehner S.C., Murry C.E., Chamberlain J.S. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat. Med. 2006, 12:787-789.
132. Gregorevic P., Blankinship M.J., Allen J.M., Chamberlain J.S. Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Mol. Ther. 2008, 16:657-664.
133. Wang Z., Kuhr C.S., Allen J.M., Blankinship M., Gregorevic P., Chamberlain J.S., Tapscott S.J., Storb R. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol. Ther. 2007, 15:1160-1166.
134. Banks G.B., Gregorevic P., Allen J.M., Finn E.E., Chamberlain J.S. Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain. Hum. Mol. Genet. 2007, 16:2105-2113.
135. Wang B., Li J., Fu F.H., Xiao X. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice. J. Orthop. Res. 2009, 27:421-426.
136. Draviam R.A., Wang B., Li J., Xiao X., Watkins S.C. Mini-dystrophin efficiently incorporates into the dystrophin protein complex in living cells. J. Muscle Res. Cell Motil. 2006, 27:53-67.